Shiavax J. Rao
@ShiavaxJRaoMD
Followers
360
Following
1K
Media
31
Statuses
351
Cardiology Fellow @GuthrieClinic | Trainee Council @PERTConsortium | Vascular Med @uvahealthnews | Former ACS @MHIM_Baltimore
Sayre, PA
Joined January 2022
In this SoTA review, we explore recent advances in novel #HCM therapies, the safety & efficacy of #CMI and summarize key American & European guideline recommendations🫀🔗👉🏻@othman_leen @KoskinaLida @metabolicmastr @MHIM_Baltimore #CardioTwitter #MedTwitter
HCM is an inherited condition marked by unexplained left ventricular hypertrophy. This SoTA review summarizes traditional therapies & explores the safety and efficacy of emerging cardiac myosin inhibitors like mavacamten & aficamten (. #HREV @ShiavaxJRaoMD.
0
3
6
RT @PERTConsortium: We’re excited to share enrollment for HI-PEITHO is now complete! With 544 patients enrolled across 72 sites in the Unit….
0
11
0
RT @VMJ_SVM: Online First! In this comprehensive review, Giao and colleagues summarize current literature on the safety and effectiveness o….
0
4
0
RT @VMJ_SVM: From the latest issue: In this insightful review, Willems and colleagues evaluate the prognostic performance of several bedsid….
0
3
0
RT @WomenAs1: 📊 A global study shows women cardiologists face higher rates of mental health conditions (33.7% vs 26.3%) & suicide ideation….
0
15
0
RT @KPHeartDoc: Exercise is a powerful, underused therapy for ischemic cardiomyopathy. This review highlights evidence-based regimens, gaps….
link.springer.com
Heart Failure Reviews - This review explores the critical role of exercise as a non-pharmacological intervention in managing ischemic cardiomyopathy (ICM), a leading cause of heart failure. It...
0
3
0
RT @metabolicmastr: People with heart disease need to exercise, but what should their programming consist of? Our review published today hi….
link.springer.com
Heart Failure Reviews - This review explores the critical role of exercise as a non-pharmacological intervention in managing ischemic cardiomyopathy (ICM), a leading cause of heart failure. It...
0
3
0
RT @JACCJournals: A #JACCAdvances updated network meta-analysis confirms that SAPT remains the safest choice for pts w/out indication for a….
0
18
0
RT @andrew_p_hill: Lucky to sit down with @PhilGenereuxMD to discuss new insights from the EARLY TAVR trial and the incidence and impact of….
0
7
0
RT @JaimeAlmandoz: 🚨In #STRIDE, 💉#semaglutide improved walking distance, symptoms, and QoL in people with #T2D + #PAD🚶♂️. First RCT to sho….
0
1
0
Discussing the #STRIDE trial with Dr. @MarcBonaca at #ACC25 @FITsOnTheGo.🔗 In patients w/ symptomatic #PAD and T2DM, #semaglutide.⬆️ Walking distance.⬆️ Quality of Life.⬆️ ABI.⬇️ Symptoms.@uvahealthnews @CUMedicalSchool @ACCinTouch .@SVM_tweets #LBCT
1
1
5
RT @Shikha_Cardio: ACC 2025 LATE BREAKING CLINICAL TRIALS - One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congr….
0
140
0
RT @a_l_bailey: One of the most important trials at @ACCinTouch #ACC25 ! Compared fluid restriction to liberal approach in #HeartFailure.….
0
214
0
RT @NEJM: Original Article: Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism (API-CAT trial) .
0
86
0
RT @MHIM_Baltimore: Our residents and chief residents presenting their research work and enjoying ACC.25! @ACCinTouch @MHIM_Baltimore #ACC….
0
4
0
RT @DFCapodanno: Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact….
0
153
0
RT @EricTopol: New @NEJM #ACC25.The global impact of 5 cardiovascular risk factors (BP, cholesterol, obesity, diabetes, smoking) on life ex….
0
163
0
RT @NEJM: Original Article: Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) (ALPACA trial) .
0
13
0